» Articles » PMID: 7219466

Steroid Antiemesis May Be Harmful

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1981 May 14
PMID 7219466
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.

Djedovic V, Lee Y, Kollara A, May T, Brown T Horm Cancer. 2018; 9(2):95-107.

PMID: 29313170 PMC: 10355875. DOI: 10.1007/s12672-017-0319-0.


Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1.

Liu L, Aleksandrowicz E, Schonsiegel F, Groner D, Bauer N, Nwaeburu C Cell Death Dis. 2017; 8(10):e3064.

PMID: 28981109 PMC: 5680577. DOI: 10.1038/cddis.2017.455.


Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.

Sundahl N, Clarisse D, Bracke M, Offner F, Vanden Berghe W, Beck I Oncoscience. 2016; 3(7-8):188-202.

PMID: 27713909 PMC: 5043069. DOI: 10.18632/oncoscience.315.


Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy.

Herrstedt J, Sigsgaard T, Nielsen H, Handberg J, Langer S, Ottesen S Support Care Cancer. 2006; 15(4):417-26.

PMID: 17093916 DOI: 10.1007/s00520-006-0158-y.


Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.

Zhang C, Kolb A, Buchler P, Cato A, Mattern J, Rittgen W BMC Cancer. 2006; 6:61.

PMID: 16539710 PMC: 1434760. DOI: 10.1186/1471-2407-6-61.